Literature DB >> 11265175

Chlamydia pneumoniae antigens, rather than viable bacteria, persist in atherosclerotic lesions.

A Meijer1, P J Roholl, S K Gielis-Proper, J M Ossewaarde.   

Abstract

AIMS: To evaluate the nature of the presence of Chlamydia pneumoniae or of other members of the order Chlamydiales in atherosclerotic lesions.
METHODS: Consecutive sections of 13 carotid artery specimens obtained at necropsy and of C pneumoniae infected HEp2 cells were analysed using: (1) immunocytochemistry (ICC) to detect C pneumoniae membrane protein; (2) in situ hybridisation (ISH) using a polymerase chain reaction (PCR) fragment of the omp1 gene to detect C pneumoniae specific DNA; (3) ISH using an oligonucleotide probe to detect Chlamydiales specific 16S rRNA; (4) PCR to detect C pneumoniae 16S rDNA; and (5) in situ DNA nick and labelling (TUNEL) to detect fragmented DNA.
RESULTS: Staining by ICC and ISH of infected HEp2 cells showed characteristic inclusions. Chlamydia pneumoniae membrane protein was demonstrated in macrophages in advanced atherosclerotic lesions (six of six), but not in fatty streaks (none of two), or normal arteries (none of five). ISH assays using both probes and PCR were all negative, indicating the absence of both specific C pneumoniae DNA and Chlamydiales specific 16S rRNA. Only after treatment with DNAse I were uniformly sized dots demonstrated by the TUNEL assay in inclusions of infected HEp2 cells. The TUNEL assay showed a similar staining pattern in macrophages in five carotid artery specimens, of which four were also positive for C pneumoniae membrane protein. Both macrophage populations were morphologically similar and were similarly distributed.
CONCLUSIONS: No evidence was obtained for the involvement of other members of the order Chlamydiales in atherosclerosis. The presence of C pneumoniae antigen in the absence of DNA and 16S rRNA suggests that antigens, rather than viable bacteria, persist in atherosclerotic lesions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11265175      PMCID: PMC1731134          DOI: 10.1136/jcp.53.12.911

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  36 in total

1.  Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis.

Authors:  L A Jackson; L A Campbell; R A Schmidt; C C Kuo; A L Cappuccio; M J Lee; J T Grayston
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

2.  Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response.

Authors:  S S Kaukoranta-Tolvanen; A M Teppo; K Laitinen; P Saikku; K Linnavuori; M Leinonen
Journal:  Microb Pathog       Date:  1996-09       Impact factor: 3.738

3.  Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group.

Authors:  J A Ramirez
Journal:  Ann Intern Med       Date:  1996-12-15       Impact factor: 25.391

4.  Molecular evidence for the existence of additional members of the order Chlamydiales.

Authors:  Jacobus M Ossewaarde; Adam Meijer
Journal:  Microbiology       Date:  1999-02       Impact factor: 2.777

Review 5.  Chlamydia pneumoniae (TWAR).

Authors:  C C Kuo; L A Jackson; L A Campbell; J T Grayston
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

Review 6.  The immunobiology and immunopathology of chlamydial infections.

Authors:  M E Ward
Journal:  APMIS       Date:  1995-11       Impact factor: 3.205

7.  Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy.

Authors:  S M Weiss; P M Roblin; C A Gaydos; P Cummings; D L Patton; N Schulhoff; J Shani; R Frankel; K Penney; T C Quinn; M R Hammerschlag; J Schachter
Journal:  J Infect Dis       Date:  1996-04       Impact factor: 5.226

8.  Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues.

Authors:  L A Campbell; E R O'Brien; A L Cappuccio; C C Kuo; S P Wang; D Stewart; D L Patton; P K Cummings; J T Grayston
Journal:  J Infect Dis       Date:  1995-08       Impact factor: 5.226

9.  Case report: in situ hybridization for detection of inapparent infection with Chlamydia trachomatis in synovial tissue of a patient with Reiter's syndrome.

Authors:  A M Beutler; H R Schumacher; J A Whittum-Hudson; W A Salameh; A P Hudson
Journal:  Am J Med Sci       Date:  1995-11       Impact factor: 2.378

10.  Further characterization of Chlamydia pneumoniae specific monoclonal antibodies.

Authors:  M Puolakkainen; J Parker; C C Kuo; J T Grayston; L A Campbell
Journal:  Microbiol Immunol       Date:  1995       Impact factor: 1.955

View more
  7 in total

1.  Positive IS900 in situ hybridization signals as evidence for role of Mycobacterium avium subsp. paratuberculosis in etiology of Crohn's disease.

Authors:  Paul J M Roholl; Arnold Herrewegh; Dick van Soolingen
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

Review 2.  Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence.

Authors:  Margareta M Ieven; Vicky Y Hoymans
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

3.  Matrix metalloproteinase-9 expression is associated with the presence of Chlamydia pneumoniae in human coronary atherosclerotic plaques.

Authors:  G Arno; J C Kaski; D A Smith; J P Akiyu; S E Hughes; C Baboonian
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

4.  Effect of clarithromycin treatment on Chlamydia pneumoniae in vascular tissue of patients with coronary artery disease: a randomized, double-blind, placebo-controlled trial.

Authors:  Hans F Berg; Boulos Maraha; Anneke van der Zee; Siska K Gielis; Paul J M Roholl; Gert-Jan Scheffer; Marcel F Peeters; Jan A J W Kluytmans
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

5.  Immunohistostaining assays for detection of Chlamydia pneumoniae in atherosclerotic arteries indicate cross-reactions with nonchlamydial plaque constituents.

Authors:  Vicky Y Hoymans; Johan M Bosmans; Dominique Ursi; Wim Martinet; Floris L Wuyts; Eric Van Marck; Martin Altwegg; Christiaan J Vrints; Margareta M Ieven
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

6.  Propionibacterium acnes Recovered from Atherosclerotic Human Carotid Arteries Undergoes Biofilm Dispersion and Releases Lipolytic and Proteolytic Enzymes in Response to Norepinephrine Challenge In Vitro.

Authors:  Bernard B Lanter; David G Davies
Journal:  Infect Immun       Date:  2015-07-27       Impact factor: 3.441

7.  Evaluation of five DNA extraction methods for purification of DNA from atherosclerotic tissue and estimation of prevalence of Chlamydia pneumoniae in tissue from a Danish population undergoing vascular repair.

Authors:  Tina Mygind; Lars Østergaard; Svend Birkelund; Jes S Lindholt; Gunna Christiansen
Journal:  BMC Microbiol       Date:  2003-09-02       Impact factor: 3.605

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.